Overview

DP-R212 Pharmacokinetic Study

Status:
Unknown status

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

An open-label, multiple-dose study to evaluate the pharmacokinetic drug-drug interaction of amlodipine and rosuvastatin in healthy adult male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Alvogen Korea

Treatments:

Amlodipine
Rosuvastatin Calcium